In the News | Friends of Cancer Research

You are here

In the News

June 28, 2018
Although patients with cancer have high rates of comorbidities that often correlate with poorer outcomes and complicate treatment decisions, hard data are frequently lacking on the interaction... Read more
June 25, 2018
Individuals with HIV are living longer than ever due to tremendous advances in treatment.   However, as survival has increased, so has the incidence of cancer. Malignancy is a leading cause of... Read more
June 22, 2018
In December 2017, the National Cancer Institute (NCI) announced that preliminary results from an NCI-sponsored phase I clinical trial​ showed it can be safe to treat HIV-positive cancer patients with... Read more
June 20, 2018
PMC to Present Ellen V. Sigal With 14th Annual Award for Leadership in Personalized Medicine Nomination letters praise Sigal as 'fundamental change agent' for field WASHINGTON (June 20, 2018) — In... Read more
June 20, 2018
In a world of major cancer advances, and a growing arsenal of innovative therapies, eligibility criteria for clinical trials haven't changed in 20 years. Edward Kim, MD, chair of solid tumor oncology... Read more
June 18, 2018
Executive Summary In addition to reviewing proposed lists of targets for relevance to pediatric cancer, advisory committee will discuss possible criteria for prioritizing same-in-class agents for... Read more
June 11, 2018
June 11, 2018 – Washington, DC – On Friday, June 8, 2018, The New York Times published an editorial titled “Easier Drug Approval Isn’t Cutting Drug Prices.” In it, The Times Editorial Board claims... Read more
June 11, 2018
Executive Summary New York Times editorial is critical of approving drugs based on one clinical trial, recommends independent cost benefit analysis.   A New York Times editorial recommending that the... Read more
June 6, 2018
Cancer Network: There are already a few immunotherapy-immunotherapy combinations approved for melanoma, and also two targeted therapy combinations. What have we learned so far about the development... Read more
June 4, 2018
A Florida woman diagnosed with advanced breast cancer, generally considered incurable, is free of the disease two-and-a-half years after a novel therapy used her own immune cells to target her tumors... Read more

Pages